Hansa Biopharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Cap	3,124	3,497	2,658	1,380
Market Cap Growth	42.42%	31.53%	92.63%	-
Enterprise Value	3,605	3,734	3,332	1,380
Last Close Price	39.42	34.36	39.20	26.20
PS Ratio	16.49	15.73	15.52	-
PB Ratio	-6.01	-39.29	-4.51	-
EV/Sales Ratio	19.03	16.80	19.45	-
Debt / Equity Ratio	-1.98	-10.45	-1.82	-
Net Debt / Equity Ratio	-	-2.67	-1.14	-
Net Debt / EBITDA Ratio	-0.82	-0.49	-1.10	-
Net Debt / FCF Ratio	-0.83	-0.43	-1.00	-
Asset Turnover	0.17	0.23	0.43	-
Inventory Turnover	11.51	19.12	64.03	-
Quick Ratio	1.23	1.87	1.75	-
Current Ratio	1.25	1.94	1.83	-
Return on Equity (ROE)	247.90%	157.36%	273.72%	-
Return on Assets (ROA)	-52.83%	-53.16%	-159.94%	-
Return on Invested Capital (ROIC)	-80.99%	-80.38%	-117.49%	-
Return on Capital Employed (ROCE)	-92.63%	-80.04%	-234.10%	-
Buyback Yield / Dilution	-42.70%	-29.23%	-19.59%	-
Total Shareholder Return	-42.70%	-29.23%	-19.59%	-